Compare · MDLN vs TRXC
MDLN vs TRXC
Side-by-side comparison of Medline Inc. (MDLN) and TransEnterix, Inc. (TRXC): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MDLN and TRXC operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN carries a market cap of $51.51B.
- MDLN has hit the wire 17 times in the past 4 weeks while TRXC has been quiet.
- MDLN has more recent analyst coverage (25 ratings vs 0 for TRXC).
- Company
- Medline Inc.
- TransEnterix, Inc.
- Price
- -
- -
- Market cap
- $51.51B
- -
- 1M return
- +10.48%
- -
- 1Y return
- -3.90%
- -
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- AMEX
- IPO
- 2025
- n/a
- News (4w)
- 17
- 0
- Recent ratings
- 25
- 0
Latest MDLN
- Medline Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
- Medline launches right-sized Ranpak packaging solutions in two key distribution centers
- SEC Form EFFECT filed by Medline Inc.
- Medline Inc. announces pricing of secondary offering of Class A common stock
- Chief Legal Officer Liberman Alexander M. was granted 798,680 units of Class B Common Stock, increasing direct ownership by 352% to 1,025,603 units (SEC Form 4)
- Chief Product Officer Laabs Amanda H. was granted 520,127 units of Class B Common Stock, increasing direct ownership by 207% to 771,197 units (SEC Form 4)
- Chief Commercial Officer Golwas Douglas P was granted 895,512 units of Class B Common Stock, increasing direct ownership by 164% to 967,560 units (SEC Form 4)
- Chief Executive Officer Boyle James M was granted 2,516,260 units of Class B Common Stock, increasing direct ownership by 7,591% to 1,869,921 units (SEC Form 4)
- Medline Inc. announces launch of secondary offering of Class A common stock
- SEC Form S-1 filed by Medline Inc.
Latest TRXC
- SEC Form 8-K filed
- SEC Form 10-K filed
- Asensus Surgical, Inc. Schedules Fourth Quarter and Fiscal Year 2020 Financial and Operating Results Conference Call for March 11, 2021
- SEC Form 8-K filed
- Asensus Surgical Announces FDA Clearance in General Surgery
- Asensus Surgical to Present at the H.C. Wainwright Virtual Global Life Sciences Conference
- SEC Form 8-K filed
- SEC Form 8-K filed
- TransEnterix Announces Name Change to Asensus Surgical and Introduces a New Category of Surgery, Performance-Guided Surgery
- TransEnterix Announces New Training Center in EU